Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...
IV drips promise quick immunity and energy fixes, but experts warn healthy people are unlikely to benefit — and they aren't ...
The agency is approaching the new overhaul as a chance to reshape drug regulations in the European Union.
Capital Market on MSN
Biocons arm inks pact to commercialize biosimilar Aflibercept Worldwide
The agreement clears the way for Biocon Biologics to commercialize Yesafili globally. Yesafili is a vascular endothelial ...
The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...
The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...
Bangkok Post on MSN
Pact aims to rev up pharma patent use
The Department of Intellectual Property (DIP) held discussions with the Food and Drug Administration (FDA) to support the targeted development of health products. The collaboration aims to enhance ...
MRAs can save resources for regulators and drug makers by, among other things, reducing the number of inspections and waiving retesting requirements.
The clinical trial is taking place for children as young as ten based on a recommendation by the Cass Review into children's ...
There has been a seven-fold increase in the number of people using weight loss jabs in the UK over the last year. | ITV News ...
The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...
The European Medicines Agency's committee on Friday recommended a change to extend the use of Eli Lilly's blockbuster drug Mounjaro for the treatment of type 2 diabetes in adolescents and children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback